Kingjims Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2024.
2024 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Kingjims Pharmaceutical Limited

Kingjims Pharmaceutical Limited, a active public limited company, was established on 21 May 2024 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U21002MH2024PLC425547. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pradeep Kumar Singh (Director), Yogendra Kumar Shriballabh Varshney (Director), Mohd Naveed Ansari (Director). Past directors included Pankaj Y Varshney, Amit Yogendra Varshney, Subhash Navneet Gupta. It is based at 5Th Floor, 5B, Technopolis Knowledgepark,, Chakala Midc, Mumbai,, Mumbai, Maharashtra, 400093.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002MH2024PLC425547

  • Registration Number

    425547

  • Incorporation Date

    21 May 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 8 Months
Company report

Kingjims Pharmaceutical Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kingjims Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kingjims Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Pradeep Kumar Singh Director 21 May 2024 Current
Yogendra Kumar Shriballabh Varshney Director 21 May 2024 Current
Mohd Naveed Ansari Director 21 May 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kingjims Pharmaceutical.

Enhance accessibility to Kingjims Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kingjims Pharmaceutical revenue growth over time
Kingjims Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kingjims Pharmaceutical?

Unlock access to Kingjims Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kingjims Pharmaceutical?

Unlock and access historical data on people associated with Kingjims Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kingjims Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kingjims Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kingjims Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    The activity Pradeep Kumar Singh was appointed as a Director was appointed as a Director on 21 May 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    Yogendra Kumar Shriballabh Varshney was appointed as a Director was appointed as a Director on 21 May 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Mohd Naveed Ansari was appointed as a Director was appointed as a Director on 21 May 2024 & has been associated with this company since 1 year 8 months . was documented.

  • Company Incorporation

    The activity Kingjims Pharmaceutical Limited was registered on 21 May 2024 with Roc Mumbai & aged 1 year 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kingjims Pharmaceutical Limited?

The CIN of Kingjims Pharmaceutical Limited is U21002MH2024PLC425547.

Where is Kingjims Pharmaceutical Limited headquartered?

Kingjims Pharmaceutical Limited is headquartered at 5Th Floor, 5B, Technopolis Knowledgepark,, Chakala Midc, Mumbai,, Mumbai, Maharashtra, 400093.

When was Kingjims Pharmaceutical Limited incorporated?

Kingjims Pharmaceutical Limited was incorporated on 21 May 2024.

Who are the current directors of Kingjims Pharmaceutical Limited?

The current directors of Kingjims Pharmaceutical Limited are

What is the primary industry of Kingjims Pharmaceutical Limited?

The primary industry of Kingjims Pharmaceutical Limited is Pharma.

Is Kingjims Pharmaceutical Limited a listed company?

Kingjims Pharmaceutical Limited is unlisted.

What is the capital structure of Kingjims Pharmaceutical Limited?

The authorized capital of Kingjims Pharmaceutical Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available